Mary  E. Edgerton
Mary E. Edgerton
Department of Pathology, UT MD Anderson Cancer Center
Verified email at
Cited by
Cited by
Proteomic patterns of tumour subsets in non-small-cell lung cancer
K Yanagisawa, Y Shyr, BJ Xu, PP Massion, PH Larsen, BC White, ...
The Lancet 362 (9382), 433-439, 2003
Significance of p63 amplification and overexpression in lung cancer development and prognosis
PP Massion, PM Taflan, SM Jamshedur Rahman, P Yildiz, Y Shyr, ...
Cancer research 63 (21), 7113-7121, 2003
Multiclonal invasion in breast tumors identified by topographic single cell sequencing
AK Casasent, A Schalck, R Gao, E Sei, A Long, W Pangburn, T Casasent, ...
Cell 172 (1), 205-217. e12, 2018
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression
P Macklin, ME Edgerton, AM Thompson, V Cristini
Journal of theoretical biology 301, 122-140, 2012
Ductal carcinoma in situ: state of the science and roadmap to advance the field
HM Kuerer, CT Albarracin, WT Yang, RD Cardiff, AM Brewster, ...
Journal of Clinical Oncology 27 (2), 279-288, 2009
Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression
PP Massion, PM Taflan, Y Shyr, SMJ Rahman, P Yildiz, B Shakthour, ...
American journal of respiratory and critical care medicine 170 (10), 1088-1094, 2004
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line
L Xie, BK Law, ME Aakre, M Edgerton, Y Shyr, NA Bhowmick, HL Moses
Breast Cancer Research 5, 1-12, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancer
N Yamagata, Y Shyr, K Yanagisawa, M Edgerton, TP Dang, A Gonzalez, ...
Clinical Cancer Research 9 (13), 4695-4704, 2003
Prediction of drug response in breast cancer using integrative experimental/computational modeling
HB Frieboes, ME Edgerton, JP Fruehauf, FRAJ Rose, LK Worrall, ...
Cancer research 69 (10), 4484-4492, 2009
The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes
L Han, Y Yuan, S Zheng, Y Yang, J Li, ME Edgerton, L Diao, Y Xu, ...
Nature communications 5 (1), 3963, 2014
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma
IM Khalifeh, C Albarracin, LK Diaz, FW Symmans, ME Edgerton, ...
The American journal of surgical pathology 32 (4), 544-552, 2008
The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data
JJ Berman, ME Edgerton, BA Friedman
BMC Medical Informatics and Decision Making 3, 1-9, 2003
Genome evolution in ductal carcinoma in situ: invasion of the clones
AK Casasent, M Edgerton, NE Navin
The Journal of pathology 241 (2), 208-218, 2017
Studies of an acid-induced species of purple membrane from Halobacterium halobium
TA Moore, ME Edgerton, G Parr, C Greenwood, RN Perham
Biochemical Journal 171 (2), 469-476, 1978
DCIS margins and breast conservation: MD Anderson Cancer Center multidisciplinary practice guidelines and outcomes
HM Kuerer, BD Smith, M Chavez-MacGregor, C Albarracin, CH Barcenas, ...
Journal of Cancer 8 (14), 2653, 2017
Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family
S Sanga, BM Broom, V Cristini, ME Edgerton
BMC medical genomics 2, 1-16, 2009
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer
PA Thompson, AM Brewster, D Kim-Anh, V Baladandayuthapani, ...
PloS one 6 (8), e23543, 2011
A novel, patient-specific mathematical pathology approach for assessment of surgical volume: application to ductal carcinoma in situ of the breast
ME Edgerton, YL Chuang, P Macklin, W Yang, EL Bearer, V Cristini
Analytical cellular pathology 34 (5), 247-263, 2011
Thermodynamics of halobacterial environments
ME Edgerton, P Brimblecombe
Canadian journal of microbiology 27 (9), 899-909, 1981
Metastatic neuroendocrine tumour in the breast: a potential mimic of in‐situ and invasive mammary carcinoma
KD Perry, C Reynolds, DG Rosen, ME Edgerton, C T Albarracin, ...
Histopathology 59 (4), 619-630, 2011
The system can't perform the operation now. Try again later.
Articles 1–20